-
Shares of Regeneron Pharmaceuticals, Inc.
REGN
rose 1.2% after the company reported that US regulators had authorized a lower-dose and subcutaneous version of its COVID-19 antibody treatment.
-
Coherus BioSciences, Inc.’s
CHRS
shares jumped 1.8% after the company and Junshi Bio jointly disclosed that toripalimab in combination with chemo met primary endpoint as the first-line treatment of metastatic nasopharyngeal carcinoma.
-
Shares of Senseonics Holdings, Inc.
SENS
surged nearly 42% after the company reported results from a study evaluating its Eversense CGM System for up to 180 days.
-
Cullinan Oncology, Inc.’s
CGEM
shares jumped 11.3% after the company disclosed Phase 1/2a interim data for its Cullinan Pearl’s CLN-081 on 20 patients.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report